期刊文献+

胶体金免疫层析法测定血清心肌型脂肪酸结合蛋白及临床应用 被引量:1

Clinical application of gold immunochromatography assay of serum heart-type fatty acid-binding protein
下载PDF
导出
摘要 目的探讨国内研制的胶体金免疫层析法(GICA)试剂测定血清心肌型脂肪酸结合蛋白(HFABP)及其在急性心肌梗死(AMI)诊断中的应用价值。方法使用心肌型脂肪酸结合蛋白快速检测试剂盒检测血清HFABP。观察急性心肌梗死患者30例,在不同时间段检测HFABP、cTnI、CKMB,并与35例健康人检测结果比较。结果HFABP快速诊断试剂盒使用简单、方便、快速,手指血检测10~15min,血清检测只需3min。其检测灵敏度较高(6.5ng/ml),特异性较高。CKMB在AMI发生后0~4h阳性检出率极低,4~12h有一定的检出率,只有在12~24h有较高的阳性检出率;cTnI在6h内有较低的阳性检出率,在6h后检出率较高,维持时间较长。HFABP在AMI发生后0~4h即有较高的阳性检出率,4~12h维持高水平的检出率。结论胶体金免疫层析法(GICA)测定HFABP简便、快捷,灵敏度、特异性较高,适用于急诊检验。HFABP在AMI发生6h内较cTnI、CKMB对早期AMI更具诊断价值。 Objective To estimate the value of gold immunochromatography assay(GICA) of serum heart-type fatty acid-binding protein for diagnosis of AMI.Methods H-FABP concentration of 35 healthy individuals and 30 AMI patients were measured by H-FABP reagent kit.cTnI,CK-MB were estimated in the same time.Results The reagent kit is rapid and simple.The test needed 10-15 min (or 3 min for serum).The sensitivity (6.5 ng/ml) and specificity are better.The detection rates of CK-MB was low in 0-4 h after attack of AMI,the lowest in 4-12 h,but higher in 12-24 h.The cTnI was detected with low deteotion rate at 6 h.The detection rate was high for long time after 6h.The H-FABP had high detection rate within 0-4 h and for 4-12 h after episode of AMI.Conclusion GICA is simple and rapid .The sensitivity and specificity are high.GICA is fit for emergercy .H-FABP has more diagnostic value than cTnI and CK-MB within 0-6 h after episode of AMI.
出处 《检验医学与临床》 CAS 2006年第3期100-101,共2页 Laboratory Medicine and Clinic
关键词 心肌型脂肪酸结合蛋白 心肌梗死 胶体金免疫层析法 Heart-type fatty acid-binding protein(HF ABP) Acute myocardial infarction Gold colloid
  • 相关文献

参考文献3

二级参考文献16

  • 1康格非 巫向前.临床生物化学和生物化学检验(第2版)[M].北京:人民卫生出版社,1999.154.
  • 2Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol, 2003, 41(4 Suppl S): 37S-42S.
  • 3Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest, 2003, 111(12): 1805-1812.
  • 4Malasky BR, Alpert JS. Diagnosis of myocardial injury by biochemical markers: problems and promises. Cardiol Rev, 2002, 10(5): 306-317.
  • 5e-Lemos JA, Morrow DA, Gibson CM, et al. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol, 2002, 40(2): 238-244.
  • 6Ghani F, Wu AH, Graff L, et al. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem, 2000, 46(5): 718-719.
  • 7Rabitzsch G, Mair J, Lechleitner P, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem, 1995, 41(7): 966-978.
  • 8Patti G, D'Ambrosio A, Mega S, et al. Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. J Am Coll Cardiol, 2004, 43(1): 35-38.
  • 9Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol, 1996, 16(1): 51-55.
  • 10Carville DG, Dimitrijevic N, Walsh M, et al. Thrombus precursor protein (TpP): marker of thrombosis early in the pathogenesis of myocardial infarction. Clin Chem, 1996, 42(9): 1537-1541.

共引文献451

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部